Life Biosciences
Life Biosciences is a Boston-based biotech company developing gene therapies that aim to reverse aging in cells. Its lead therapy, ER-100, is in human trials for vision loss caused by glaucoma and other optic nerve diseases.
Analytics date: 05.11.2026
Basic information
Head office
75 Park Plaza, Level Three, Boston, MA 02116, USAHead officeGeography of business
United States of America- Singapore
Geography of businessDate of the last round
Last round 04/2026Date of the last roundTotal funds raised
$212M+Total funds raised
Analytics date: 05.11.2026
Financial indicators
000
000 00000 0 00 0 000 00 0 0 0 00 0000000 0 0 000 0 0 000 000 00000 000 00000 000000000000000000000000000000000000000000000000
0000000
00 0 0 0 00 00 0 000 0000 000 0 0 00 000 00000000000000000000000000000000000000000000000000000000000000
000 00
00 0 0 0 0 0 0 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
00 0 000
0 000 0 00 0 0 00 0 000 00000000000000000000000000000000
0000 0 0 00
000 00 0 0 0 0 0000 0 0 000 00 000 0 000 00 0 0 0000000000000000000000000000000000000000000
0000
0 0000 00 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
000000 0000000 00000 0000 000000000 00000 00000000 0000000 000000000 000000000000 0000000 000000000 00000 000 00000000 000 0000 0000000000000 00000000 00 00000 000000 00000 00000000000 000000 000000000 00000000 00000 000000 000 00000 00000 00000000 0000000 00000 00000 0000000000 000 00000 00000000000 0 000 0000 00000000000 00000000 0000000 00000 000000 00000 00000000 00000 00000000000 0000 0000000 00000 0000 0000000
00000 00000 00000 000 00000 00000000000 00000000000 00000 00000 0000000000 00000000000 00000 0000 0000 00000000 0000000 000000000 000 000 00000 0000 0000000 0000000 00000000000 0000000000 00000000000 0000000000 0000000000 00000000 00000 00000000 000000 000000 00000 0000 000 0000000 0000000 00000000000 000000000 00000000 00000000000 00000000000 000000 00000000 00000000 00000 0000000000 0000000 000 00000000000000 000000 0000000 0000 000000 000 0000 00000 000000000 0000 0000000 000 000000 00000000 0000000000000 00000 000000000000000
0000000 00 000000000 0000000000 000 00000 0000000000 00000000 000 0000000000 0000000 00000000 00000000000 0000000000 0000000 00000 000 00000 0000 00000 000 0000 0000000 000000 0000 00000 000000 000000 0000000 00000 0000
000000000 00000 00000000 0000000 000000000 000000000000 0000000 000000000 00000 000 00000000 000 0000 0000000000000 00000000 00 00000 000000 00000 00000000000 000000 000000000 00000000 00000 000000 000 00000 00000 00000000 0000000 00000 00000 0000000000 000 00000 00000000000 0 000 0000 00000000000 00000000 000 0000 000000 00000 0000 000000000 000000000000 000 00000000 0000000 00000 000000000 00 0000000 000000 00000000 000000000 000000 000000 0000000000 00000 000000000000 00000000 00000 00000 00000 0000 000 0000000000 000000000000 000000 0000000000 0000 00000000000000 00000000 00000000 000 00 000000000
Request price
Key financial indicators
| Revenue |
| Employees | |
| 0 00 000 | ... |
Competitor Analysis
Comparison to other companies in the industry.
| Name | Evaluation |
| Private companies | |
Isomorphic Labs | ... |
Ultima Genomics | $ 1.4B |
Colossal Biosciences | $ 5.2B |
Varda Space Industries | $ 1.5B |
Mammoth Biosciences | $ 800M |
| Traded companies | |
Recursion Pharmaceuticals | $ 2.3B |
Schrödinger | $ 2B |
Relay Therapeutics | $ 3.8B |
Scribe Therapeutics | $ 294.2M |
Metagenomi Therapeutics | $ 28.5M |